Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation and platelet sensitivity-behaviour during normal and abnormal glucose tolerance testing.

I Virgolini, J Kaliman, H Sinzinger

    VASA. Zeitschrift Fur Gefasskrankheiten
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished.

    Thrombosis research·1995
    Same author

    Passive smoking and cardiovascular risk.

    Archives of internal medicine·1995
    Same author

    Gamma irradiation is not a novel approach to inhibit neointimal hyperplasia after arterial injury.

    Stroke·1995
    Same author

    Arterial wall rather than platelets is responsible for diminished thrombogenicity during isradipine therapy.

    Journal of cardiovascular pharmacology·1995
    Same author

    Evidence for lipid regression in humans in vivo performed by 123iodine-low-density lipoprotein scintiscanning.

    Annals of the New York Academy of Sciences·1995
    Same author

    [1995 consensus guidelines for cholesterol. Society of Physicians in Vienna].

    Wiener klinische Wochenschrift·1995

    Abnormal glucose tolerance is linked to reduced platelet sensitivity to prostaglandin I2 (PGI2). This study investigated platelet aggregation and PGI2 sensitivity during glucose tolerance testing in patients and healthy volunteers.

    Area of Science:

    • Cardiovascular Research
    • Endocrinology
    • Hematology

    Background:

    • Platelet aggregation plays a crucial role in hemostasis and thrombosis.
    • Prostaglandin I2 (PGI2) is a potent endogenous inhibitor of platelet aggregation.
    • Glucose metabolism disorders, like abnormal glucose tolerance, can impact vascular function.

    Purpose of the Study:

    • To investigate the effect of intravenous glucose tolerance testing (GTT) on platelet aggregation response to ADP.
    • To assess changes in platelet sensitivity to prostaglandin I2 (PGI2) during GTT.
    • To determine if abnormal glucose tolerance is associated with altered platelet function.

    Main Methods:

    • Measured platelet aggregation response to ADP in 15 patients and 8 healthy volunteers.
    • Assessed platelet sensitivity to PGI2 during intravenous glucose tolerance testing (GTT).

    Related Experiment Videos

  • Compared results between patients with pathological GTT, patients with normal GTT, and healthy volunteers.

    • Main Results:

    • Patients with pathological GTT showed a diminished slope of ADP-induced aggregation and significantly decreased platelet sensitivity to PGI2 during GTT.
    • Platelet sensitivity to PGI2 returned to pre-test values by the end of GTT in patients with pathological GTT.
    • No significant changes in platelet aggregation or PGI2 sensitivity were observed during GTT in patients with normal GTT or healthy volunteers, although healthy volunteers had lower baseline PGI2 sensitivity.

    Conclusions:

    • Abnormal glucose tolerance is associated with impaired platelet sensitivity to PGI2.
    • These findings suggest a potential link between metabolic dysfunction and altered platelet reactivity.
    • Further research is warranted to elucidate the mechanisms underlying this association and its clinical implications.